PA
BIIB icon

Perennial Advisors’s Biogen BIIB Stock Holding History

Perennial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-55
Closed -$15K – 211
2018
Q1 		$15K Hold
55
– – 0.01% 150
2017
Q4 		$18K Hold
55
– – 0.01% 149
2017
Q3 		$17K Sell
55
-15
-21% -$4.44K 0.01% 139
2017
Q2 		$19K Hold
70
– – 0.01% 134
2017
Q1 		$19K Hold
70
– – 0.01% 124
2016
Q4 		$20K Buy
+70
New +$20.8K 0.02% 124

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Perennial Advisors's BIIB Position: Q2 2018 in Review

Perennial Advisors sold out of Biogen (BIIB) in Q2 2018, closing a stake of 55 shares — an estimated $15K sold.

Perennial Advisors first reported a position in BIIB in Q4 2016 and held it in 6 quarters. The position peaked at $20K in Q4 2016. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Perennial Advisors reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Perennial Advisors sold 55 Biogen shares in Q2 2018, an estimated $15K.
  • Perennial Advisors first reported a position in Biogen in Q4 2016 and held it in 6 quarters.
  • Perennial Advisors's Biogen position peaked at $20K in Q4 2016.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Perennial Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.